Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2005
08/23/2005US6933374 Plant lyase protein for producing taste products, drugs, pigments and hop secondary metabolites; alcoholic beverages
08/23/2005US6933373 Tumor suppressor protein for as a antiproliferative agent
08/23/2005US6933368 Increasing antibody affinity by altering glycosylation of immunoglobulin variable region
08/23/2005US6933365 Mutant tyrosine repressor proteins
08/23/2005US6933364 Secretory thyroid stimulating hormone receptor, and method for assaying anti-thyroid stimulating hormone receptor antibody using the same
08/23/2005US6933271 Aimed at neoplastic cells with gonadotropin releasing hormone binding sites; anticarcinogenic agents; genetically engineered Pseudomonas Exotoxin
08/23/2005US6933147 Human cyclic nucleotide-gated channel polypeptide
08/23/2005US6933146 Methods and means for producing efficient silencing construct using recombinational cloning
08/23/2005US6933145 Materials and methods for delivery and expression of heterologous DNA in vertebrate cells
08/23/2005US6933142 Mammalian glycosylsulfotransferases expressed in high endothelial cells (HEC-GLCNAC6ST) and polypeptides coded by nucleic acids, used for medical diagnosis, drug screening and therapy
08/23/2005US6933138 Comprises nucleotide sequences coding heat resistant isomerase for preparation of sugar substitute; diabetes preventive agent; detergents and cosmetics additive
08/23/2005US6933136 Method for making recombinant proteins
08/23/2005US6933135 monoclonal antibody having intracellular domain of leukocyte antigen related molecule and domain of CD45; for prophylaxis and diagnosis of syndrome X, arteriosclerosis, and cardiovascular disorders based on insulin resistance
08/23/2005US6933133 Treatment of diabetes with synthetic beta cells
08/23/2005US6933132 Regulation of immune responses by attractin
08/23/2005US6933131 Nucleotide sequences for use in biological pest control; insecticides
08/23/2005US6933130 Recombinants process for preparing a complete malaria antigen, gp190/MSP1
08/23/2005US6933125 Human c-Maf compositions and methods of use thereof
08/23/2005US6933124 Human GABAB receptor 1 promoters
08/23/2005US6933118 Detection polymorphism of genes; testing using primer Dna; calibration
08/23/2005US6933116 Nucleic acid ligand binding site identification
08/23/2005US6933114 Nucleotide sequence ligand for use in the detection diagnosis and treatment of cancer
08/23/2005US6933113 Modulation of endogenous gene expression in cells
08/23/2005US6933111 Glufosinate tolerant rice
08/23/2005US6933110 Trypanosoma cruzi antigen, gene encoding therefor and methods of detecting and treating chagas disease
08/23/2005US6932969 Ig fractions having immunomodulatory activity
08/23/2005US6932965 Separation of deamidated and non-deamidated human dnases and use of the non-deamidated species as a pharmaceutical per se; administering to patients suffering from pulmonary distress
08/23/2005CA2476033A1 Method for screening a substance which can suppress degradation of a nuclear receptor or a substance which can promote degradation of a nuclear receptor
08/23/2005CA2368734C Method for preparing monoclonal antibody
08/23/2005CA2267661C Variants of vascular endothelial cell growth factor having antagonistic properties
08/23/2005CA2193122C Tetracycline-regulated transcriptional modulators
08/23/2005CA2186044C Novel mutated viruses, anti-viral compounds and novel methods of making vaccines
08/23/2005CA2178589C Process for producing l-lysine by fermentation
08/23/2005CA2142300C Methods for detecting alzheimer's disease
08/23/2005CA2108000C Enhanced gene expression in plants using an hsp70 intron sequence
08/23/2005CA2094464C Mutant respiratory syncytial virus (rsv) vaccines containing same and methods of use
08/23/2005CA2094276C Antibodies against the urokinase receptor and their use
08/18/2005WO2005075685A1 Genes associated with canine osteoarthritis and related methods and compositions
08/18/2005WO2005075680A1 Method of detecting nucleic acid and utilization thereof
08/18/2005WO2005075676A1 Sequence-specific dna analysis
08/18/2005WO2005075674A1 Diagnostic and therapeutic use of kcne4 gene and protein for alzheimer disease
08/18/2005WO2005075660A1 Improved composition for cell-free protein synthesis
08/18/2005WO2005075657A1 Method of converting base in dna sequence
08/18/2005WO2005075656A1 Biochip electroporator and its use in multi-site, single-cell electroporation
08/18/2005WO2005075655A2 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use
08/18/2005WO2005075654A1 Generation of recombinant genes in saccharomyces cerevisiae
08/18/2005WO2005075653A1 Cell surface expression vector of parvovirus antigen and microorganisms transformed thereof
08/18/2005WO2005075652A1 Process for producing modified ϝ-glutamyltranspeptidase (modified ggt) having enhanced glutaryl-7-aminosephalosporanic acid (gl-7-aca) acylase activity
08/18/2005WO2005075651A1 Process for producing optically active alcohol and carboxylic acid
08/18/2005WO2005075650A1 Polypeptide having amidase activity and gene thereof
08/18/2005WO2005075649A1 Method of producing recombinant sucrose synthase, use thereof in the production of sucrose-determination kits, method of producing adpglucose and method of obtaining transgenic plants having leaves and reserve organs which accumulate a high concentration of adpglucose and starch
08/18/2005WO2005075645A1 Therapeutic molecules and methods for generating and/or selecting same
08/18/2005WO2005075644A2 Leader sequence and method for synthesizing polypepides in cell-free systems
08/18/2005WO2005075643A1 Method for preparing single-stranded dna
08/18/2005WO2005075642A1 Method for simultaneous extraction of nucleic acids from a biological sample
08/18/2005WO2005075641A1 Screening method
08/18/2005WO2005075638A1 Gene detection field-effect device and method of analyzing gene polymorphism therewith
08/18/2005WO2005075637A2 Screening assays
08/18/2005WO2005075632A2 Treatment of neurodegenerative diseases by the use of atp7a-modulators
08/18/2005WO2005075631A1 Process for the preparation of l-amino acids with amplification of the zwf gene
08/18/2005WO2005075626A1 MICROORGANISM PRODUCING L-THREONINE HAVING INACTIVATED tyrR GENE, METHOD OF PRODUCING THE SAME AND METHOD OF PRODUCING L-THREONINE USING THE MICROORGANISM
08/18/2005WO2005075506A1 Identification of endogenous trimerization domains in the adenovirus fiber protein that allow detargeting and retargeting of viral vectors
08/18/2005WO2005074995A2 Combined use of prame inhibitors and hdac inhibitors
08/18/2005WO2005074988A1 Nerve cell differentiation inducer
08/18/2005WO2005074981A2 Inhibitors of tgf-r signaling for treatment of cns disorders
08/18/2005WO2005074676A1 Genetic modification of c57 mice
08/18/2005WO2005074656A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
08/18/2005WO2005074647A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
08/18/2005WO2005074560A2 Compositions and methods that enhance rna interference
08/18/2005WO2005074511A2 Methods and compositions for homozygous gene inactivation using collections of pre-defined nucleotide sequences complementary to chromosomal transcripts
08/18/2005WO2005074470A2 Kits and methods for making large recombinant polynucleotides
08/18/2005WO2005074436A2 Self-assembling split-fluorescent protein systems
08/18/2005WO2005074357A2 Regulation of gene expression in plant cells
08/18/2005WO2005059135A3 Treatment of mammals by sirna delivery into mammalian nerve cells
08/18/2005WO2005058369A3 Compositions of l-caldesmon for treating viral infection
08/18/2005WO2005056145A3 Biological chip and use thereof
08/18/2005WO2005055930A3 Recombinant factor viii having increased specific activity
08/18/2005WO2005052168A3 System for the inducible expression of recombinant proteins in cyanobacteria
08/18/2005WO2005052159A8 Latent phase viral interleukin-10-(vii-10) and uses thereof
08/18/2005WO2005052123A3 Polynucleotide encoding a novel human g-protein coupled receptor variant of the relaxin receptor, hgprbmy5v1, and variants thereof
08/18/2005WO2005047487A8 Motoneuronotrophic factor gene sequences
08/18/2005WO2005045041A3 Rna interference mediated inhibition of cholesteryl ester transfer protein (cetp) gene expression using short interfering nucleic acid (sina)
08/18/2005WO2005039632B1 Colorectal cancer antigen
08/18/2005WO2005037323A3 Use of gro to treat or prevent inflammation
08/18/2005WO2005023865A3 Antibody-producing cell lines expressing activation-induced-cytidine-deaminase and a dominant negative allele of a mismatch repair gene
08/18/2005WO2005018549A3 Methods and compositions for tissue repair
08/18/2005WO2005017125A3 Method for isolation and replication of infectious human hepatitis-c virus
08/18/2005WO2005013899A3 Compositions and methods for the therapy and diagnosis of lung cancer
08/18/2005WO2005010044A3 Il-17 a/f heterologous polypeptides and therapeutic uses thereof
08/18/2005WO2005007854A3 Polycationic compositions for cellular delivery of polynucleotides
08/18/2005WO2005007691A3 East coast fever vaccine based on ctl-specific schizont antigens
08/18/2005WO2005001128A3 Materials and methods for producing dna libraries and detecting and identifying microorganisms
08/18/2005WO2005001096A8 Vaccines against sars
08/18/2005WO2004085469A3 Secreted protein family
08/18/2005WO2004084821A3 Hemipteran glutamate decarboxylase
08/18/2005WO2004083365A3 Compounds and their use for specific and simultaneous inhibition of genes involved in diseases and related drugs
08/18/2005WO2004076622A3 Regulation of gene expression by dna interference
08/18/2005WO2004072246A3 Polymerase-based protocols for the introduction of combinatorial deletions and insertions
08/18/2005WO2004067727A8 Mixing and matching tc proteins for pest control
08/18/2005WO2004062366A3 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots
1 ... 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 ... 4023